A multi-institution team led by a Weill Cornell Medicine scientist has been approved for $30 million in funding from the Patient-Centered Outcomes Research Institute to study heart procedure outcomes in underrepresented groups.
During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
A Cornell-led study provides the strongest evidence yet that omega-3 fatty acids, which are abundant in fish and fish oil supplements, may be important for lung health.
An interdisciplinary research team received a five-year, $2 million grant from the National Science Foundation to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43%, from 5.3% to 7.6% a year.
Denise Rose worked with other Cornell students on a study of mental health in India through the Cornell-Keystone Nilgiris Field Learning Summer Program.
Cornell researchers attached large fragments to temperamental "radical" molecules, increasing their girth to insulate them from their hyperreactive partners – a method that could help create improved derivatives of pharmaceutical compounds.
Researchers sent a menstrual cup to space to test if it was safe for menstruating astronauts to use, which could be especially useful on longer missions to Mars or the moon.
Professor Sean Nicholson, director of the Cornell Sloan Program in Health Administration, explores the future of biopharma with industry experts in the Keynote webcast “Bringing New Science to Market.”
